Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics Are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia
Treatment of behavioral and psychological symptoms of dementia (BPSD) and comorbidities often necessitates the concomitant use of antipsychotics and non-antipsychotic drugs, thereby potentiating the risk for drug-drug interactions (DDIs). The primary objective of our study was to identify potentiall...
Saved in:
Main Authors: | Adriana Matos (Author), Kevin T. Bain (Author), David L. Bankes (Author), Anna Furman (Author), Briana Skalski (Author), James Verzicco (Author), Jacques Turgeon (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Succinic acid inhibits the activity of cytochrome P450 (CYP450) enzymes
by: Hao Wang, et al.
Published: (2020) -
Modeling of interactions between xenobiotics and cytochrome P450 (CYP) enzymes
by: Hannu eRaunio
Published: (2015) -
Isoform CYP1A2, as a part of the cytochrome P450 superfamily
by: Y. G. Novickaya, et al.
Published: (2014) -
Nonalcoholic Fatty Liver Disease (NAFLD) and Hepatic Cytochrome P450 (CYP) Enzymes
by: Rohitash Jamwal, et al.
Published: (2020) -
Pharmacokinetic interaction of drugs, the metabolisable cytochrome P450 isoenzyme CYP2C9
by: O. G. Gribakina, et al.
Published: (2020)